— Know what they know.
Not Investment Advice
Also trades as: 0M29.L (LSE) · $vol 1M · XY6.DE (XETRA) · $vol 0M

XYL NYSE

Xylem Inc.
1W: +4.7% 1M: +5.6% 3M: -13.3% YTD: -20.7% 1Y: -26.4% 3Y: +20.7% 5Y: -8.9%
$94.41
-13.83 (-12.78%)
 
Weekly Expected Move ±2.7%
$103 $106 $109 $112 $115
NYSE · Industrials · Industrial - Machinery · Tech Score Buy · Power 70 · $25.3B mcap · 233M float · 0.925% daily turnover · Short 72% of daily vol
Credit Risk of going bust: lower than 86% of companies Debt: 10.8% of company value Bonds: $55.8M held by 167 funds, 60 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.86 (down 99.2%), Xylem Inc. would be worth roughly what it owes.
Total debt $3.06B against a stock market value of $25.27B.
Distance to default 11.49 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.73B (short-term plus half of long-term), stock volatility 25.6%; Altman Z 3.40. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.8 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 8.6%  ·  5Y Avg: 6.8%
Cost Advantage
50
Intangibles
64
Switching Cost
65
Network Effect
57
Scale
53
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. XYL has a Narrow competitive edge (58.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. ROIC of 8.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$112
Low
$143
Avg Target
$165
High
Based on 10 analysts since Jul 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 18Hold: 21Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$142.90
Analysts10
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-19 Stifel Nicolaus Nathan Jones $160 $141 -19 +35.5% $104.07
2026-10-13 Barclays William Grippin $159 $139 -20 +35.5% $102.59
2026-10-05 UBS — $138 $112 -26 +10.0% $101.84
2026-08-24 Jefferies — $140 $150 +10 +31.7% $113.87
2026-08-13 UBS — $135 $138 +3 +13.2% $121.93
2026-07-30 UBS Joshua Spector $133 $135 +2 +15.9% $116.48
2026-07-29 Mizuho Securities — $138 $130 -8 +4.0% $124.97
2026-07-29 Stifel Nicolaus — $157 $160 +3 +28.0% $124.97
2026-07-29 Robert W. Baird Michael Halloran $161 $165 +4 +32.0% $124.97
2026-07-29 Barclays — $154 $159 +5 +27.2% $124.97
2026-07-20 Stifel Nicolaus — $159 $157 -2 +27.9% $122.78
2026-07-16 RBC Capital — $176 $159 -17 +27.7% $124.53
2026-06-25 Jefferies Stephen Volkmann Initiated $140 — +25.0% $112.04
2026-04-29 UBS — $132 $133 +1 +14.3% $116.40
2026-04-29 Oppenheimer Bryan Blair $165 $158 -7 +35.7% $116.40
2026-04-29 Stifel Nicolaus — $163 $159 -4 +34.8% $117.91
2026-04-29 Barclays — $166 $154 -12 +30.6% $117.91
2026-04-21 UBS — $152 $132 -20 +9.6% $120.46
2026-04-14 Stifel Nicolaus Nathan Jones $175 $163 -12 +26.5% $128.85
2026-04-09 UBS Joshua Spector $155 $152 -3 +17.5% $129.40
2026-02-13 UBS Joshua Spector $168 $155 -13 +20.9% $128.21
2026-02-12 Oppenheimer — $152 $165 +13 +29.9% $127.02
2026-02-11 Goldman Sachs — $107 $158 +51 +24.6% $126.77
2026-02-11 Mizuho Securities — $150 $138 -12 +7.7% $128.19
2026-02-11 Stifel Nicolaus — $178 $175 -3 +35.7% $128.92
2026-02-11 Robert W. Baird — $178 $161 -17 +24.9% $128.92
2026-01-07 Barclays William Grippin $172 $166 -6 +17.5% $141.33
2026-01-05 Mizuho Securities Brett Linzey $160 $150 -10 +9.4% $137.11
2025-10-29 Stifel Nicolaus — $133 $178 +45 +16.0% $153.43
2025-10-29 Argus Research — $165 $170 +5 +10.8% $153.40
2025-10-29 Mizuho Securities Brett Linzey $135 $160 +25 +6.3% $150.50
2025-10-29 RBC Capital — $162 $176 +14 +14.7% $153.48
2025-10-29 Robert W. Baird Michael Halloran $170 $178 +8 +16.0% $153.48
2025-10-29 Barclays William Grippin $165 $172 +7 +14.3% $150.50
2025-09-18 Barclays — Initiated $165 — +16.1% $142.18
2025-08-05 UBS — $165 $168 +3 +17.0% $143.61
2024-08-13 UBS Damian Karas Initiated $165 — +29.4% $127.50
2024-07-31 Robert W. Baird Michael Halloran $155 $170 +15 +27.4% $133.48
2024-05-31 Oppenheimer Bryan Blair Initiated $152 — +9.0% $139.40
2024-05-29 Argus Research John Eade $150 $165 +15 +17.6% $140.36
2024-05-03 Mizuho Securities Brett Linzey Initiated $135 — -0.7% $135.99
2024-05-03 RBC Capital Deane Dray $153 $162 +9 +19.1% $135.99
2024-05-03 Robert W. Baird Michael Halloran Initiated $155 — +14.0% $135.99
2024-04-08 Wolfe Research Brad Hewitt Initiated $143 — +11.5% $128.27
2024-04-04 RBC Capital Deane Dray Initiated $153 — +20.2% $127.25
2023-08-18 Stifel Nicolaus Nathan Jones Initiated $133 — +33.3% $99.80
2023-02-08 Citigroup — $123 $121 -2 +13.2% $106.85
2022-12-09 Citigroup — $131 $123 -8 +10.6% $111.23
2022-11-15 Atlantic Equities Richard Radbourne Initiated $129 — +15.0% $112.13
2021-11-21 Loop Capital Markets Scott Graham Initiated $120 — -5.7% $127.19

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
4
ROE
1
ROA
1
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. XYL receives an overall rating of C. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-27 B+ C
2026-07-29 C B+
2026-07-28 B+ C
2026-05-18 A- B+
2026-05-04 B+ A-
2026-04-28 C B+
2026-04-28 B+ C
2026-04-24 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 60 Grade A
Profitability
45
Balance Sheet
72
Earnings Quality
76
Growth
48
Value
50
Momentum
77
Safety
90
Cash Flow
58
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. XYL scores highest in Safety (90/100) and lowest in Profitability (45/100). An overall grade of A places XYL among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.63
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.56
Unlikely Manipulator
Ohlson O-Score
-9.10
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 84.5/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.29x
Accruals: -1.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. XYL scores 3.63, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. XYL scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. XYL's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. XYL's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. XYL receives an estimated rating of AA- (score: 84.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). XYL's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
23.41x
PEG
2.66x
P/S
2.52x
P/B
2.26x
P/FCF
29.13x
P/OCF
21.50x
EV/EBITDA
15.99x
EV/Revenue
3.26x
EV/EBIT
22.95x
EV/FCF
30.98x
Earnings Yield
3.61%
FCF Yield
3.43%
Shareholder Yield
5.89%
Graham Number
$65.05
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 23.4x earnings, XYL commands a growth premium. Graham's intrinsic value formula yields $65.05 per share, 66% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.793
NI / EBT
×
Interest Burden
0.982
EBT / EBIT
×
EBIT Margin
0.142
EBIT / Rev
×
Asset Turnover
0.529
Rev / Assets
×
Equity Multiplier
1.607
Assets / Equity
=
ROE
9.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. XYL's ROE of 9.4% is driven by Asset Turnover (0.529), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$164.37
Price/Value
0.72x
Margin of Safety
28.08%
Premium
-28.08%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with XYL's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. XYL actually compounded EPS at 35.9% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. XYL trades at a -28% premium to its adjusted intrinsic value of $164.37, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 23.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$108.34
Median 1Y
$110.39
5th Pctile
$68.48
95th Pctile
$178.62
Ann. Volatility
29.6%
Analyst Target
$142.90
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Patrick K. Decker
President and CEO
$1,188,923 $5,205,980 $10,825,450
William K. Grogan
SVP and CFO
$195,192 $3,792,692 $4,624,898
Matthew F. Pine
SVP and COO
$647,896 $1,542,460 $3,685,950
Sandra E. Rowland
Former SVP and CFO (through September 30, 2023)
$746,769 $1,311,059 $3,594,588
Hayati Yarkadas SVP
and President, Europe, WI and GS
$596,891 $1,311,059 $3,194,510
Franz W. Cerwinka
SVP & President, AWS & GPT
$547,817 $578,399 $2,488,792

CEO Pay Ratio

124:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,825,450
Avg Employee Cost (SGA/emp): $87,409
Employees: 22,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
22,000
-4.3% YoY
Revenue / Employee
$410,682
Rev: $9,035,000,000
Profit / Employee
$43,500
NI: $957,000,000
SGA / Employee
$87,409
Avg labor cost proxy
R&D / Employee
$10,273
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 15.5% 13.8% 13.8% 13.5% 10.1% 10.6% 11.0% 5.4% 7.5% 8.9% 9.6% 7.6% 8.1% 8.6% 8.6% 8.8% 8.7% 8.7% 8.9% 9.4% 9.40%
ROA 5.6% 5.0% 5.0% 5.0% 3.9% 4.4% 4.6% 2.9% 4.1% 5.1% 5.6% 4.8% 5.2% 5.5% 5.6% 5.7% 5.7% 5.6% 5.8% 5.8% 5.85%
ROIC 12.2% 11.2% 10.5% 10.3% 10.7% 11.2% 10.9% 4.1% 4.4% 5.4% 5.9% 6.8% 7.3% 7.1% 7.1% 7.2% 7.5% 8.2% 8.1% 8.6% 8.58%
ROCE 9.2% 8.5% 8.9% 8.8% 6.9% 7.7% 8.0% 3.6% 4.8% 4.9% 5.6% 6.5% 6.9% 8.0% 8.0% 8.0% 8.1% 8.2% 8.7% 8.9% 8.87%
Gross Margin 37.3% 37.3% 36.7% 38.1% 38.0% 38.0% 37.7% 37.8% 36.8% 35.7% 37.0% 37.8% 37.3% 38.0% 37.1% 38.8% 38.9% 38.9% 37.8% 41.2% 41.22%
Operating Margin 12.0% 10.6% 8.7% 10.7% 12.2% 13.1% 9.0% 6.9% 9.2% 10.0% 10.3% 11.7% 13.3% 11.8% 11.2% 13.3% 14.7% 14.7% 11.5% 16.7% 16.70%
Net Margin 9.0% 8.5% 6.4% 8.2% 0.9% 9.9% 6.8% 5.3% 7.3% 12.6% 7.5% 8.9% 10.3% 14.5% 8.2% 9.8% 10.0% 14.0% 8.7% 11.3% 11.26%
EBITDA Margin 17.1% 15.0% 13.3% 15.2% 6.3% 17.4% 13.5% 12.7% 16.7% 17.0% 16.9% 18.6% 20.0% 23.3% 17.9% 19.7% 19.6% 21.6% 18.3% 21.9% 21.88%
FCF Margin 9.8% 6.4% 5.1% 2.7% 4.2% 7.0% 7.9% 5.9% 7.5% 7.7% 8.2% 10.6% 9.8% 11.0% 10.3% 10.1% 10.4% 10.1% 10.6% 10.5% 10.52%
OCF Margin 13.1% 10.4% 9.3% 7.0% 8.5% 10.8% 11.5% 9.5% 11.0% 11.4% 11.9% 14.4% 13.6% 14.8% 14.0% 14.0% 14.3% 13.7% 14.5% 14.3% 14.26%
ROE 3Y Avg snapshot only 8.52%
ROE 5Y Avg snapshot only 8.46%
ROA 3Y Avg snapshot only 5.38%
ROIC 3Y Avg snapshot only 6.60%
ROIC Economic snapshot only 7.88%
Cash ROA snapshot only 7.50%
Cash ROIC snapshot only 10.66%
CROIC snapshot only 7.87%
NOPAT Margin snapshot only 11.47%
Pretax Margin snapshot only 13.95%
R&D / Revenue snapshot only 2.49%
SGA / Revenue snapshot only 21.20%
SBC / Revenue snapshot only 0.45%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 46.20 48.58 34.94 32.16 47.67 54.48 49.39 64.23 43.65 44.32 46.43 42.43 39.08 31.41 31.86 33.44 37.87 34.72 29.89 27.69 23.410
P/S Ratio 4.07 3.99 2.83 2.59 2.85 3.50 3.22 3.73 3.18 3.67 3.87 3.87 3.85 3.27 3.36 3.59 4.04 3.68 3.20 3.06 2.515
P/B Ratio 6.90 6.45 4.61 4.24 4.73 5.54 5.14 2.28 2.16 2.66 3.02 3.14 3.06 2.63 2.67 2.83 3.20 2.89 2.65 2.68 2.262
P/FCF 41.53 62.86 55.65 96.04 67.58 49.85 40.83 63.33 42.36 47.69 47.44 36.47 39.17 29.67 32.47 35.61 38.81 36.51 30.11 29.13 29.131
P/OCF 31.03 38.55 30.53 37.20 33.49 32.45 27.92 39.46 28.87 32.25 32.58 26.94 28.38 22.13 23.92 25.63 28.20 26.78 22.10 21.50 21.495
EV/EBITDA 25.85 26.32 20.07 18.84 24.84 28.02 25.91 32.16 22.67 25.32 25.38 23.21 21.96 17.10 17.42 18.27 20.52 18.89 16.83 15.99 15.992
EV/Revenue 4.31 4.22 3.10 2.85 3.08 3.68 3.42 4.05 3.43 3.85 4.05 4.02 3.98 3.38 3.48 3.70 4.14 3.73 3.34 3.26 3.259
EV/EBIT 36.07 37.31 28.66 26.99 38.52 41.52 37.91 49.81 34.96 41.47 42.44 37.88 34.55 25.60 26.13 27.03 30.16 27.84 24.60 22.95 22.951
EV/FCF 44.00 66.37 60.89 105.67 73.10 52.44 43.30 68.64 45.65 50.11 49.63 37.92 40.52 30.74 33.68 36.69 39.78 37.02 31.40 30.98 30.984
Earnings Yield 2.2% 2.1% 2.9% 3.1% 2.1% 1.8% 2.0% 1.6% 2.3% 2.3% 2.2% 2.4% 2.6% 3.2% 3.1% 3.0% 2.6% 2.9% 3.3% 3.6% 3.61%
FCF Yield 2.4% 1.6% 1.8% 1.0% 1.5% 2.0% 2.4% 1.6% 2.4% 2.1% 2.1% 2.7% 2.6% 3.4% 3.1% 2.8% 2.6% 2.7% 3.3% 3.4% 3.43%
PEG Ratio snapshot only 2.658
Price/Tangible Book snapshot only 1864.361
EV/OCF snapshot only 22.863
EV/Gross Profit snapshot only 8.306
Acquirers Multiple snapshot only 22.517
Shareholder Yield snapshot only 5.89%
Graham Number snapshot only $65.05
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.33 2.27 1.62 1.63 1.65 1.89 2.01 1.64 1.72 1.76 1.67 1.85 1.96 1.75 1.89 1.90 1.96 1.62 1.46 1.61 1.613
Quick Ratio 1.81 1.77 1.21 1.19 1.22 1.39 1.44 1.14 1.21 1.30 1.22 1.33 1.42 1.33 1.41 1.43 1.50 1.28 1.10 1.24 1.240
Debt/Equity 0.82 0.78 0.78 0.77 0.75 0.56 0.54 0.26 0.24 0.24 0.23 0.20 0.20 0.20 0.20 0.19 0.19 0.17 0.19 0.29 0.293
Net Debt/Equity 0.41 0.36 0.43 0.43 0.39 0.29 0.31 0.19 0.17 0.13 0.14 0.12 0.11 0.09 0.10 0.09 0.08 0.04 0.11 0.17 0.171
Debt/Assets 0.31 0.30 0.30 0.30 0.30 0.25 0.25 0.16 0.15 0.15 0.15 0.13 0.13 0.13 0.13 0.12 0.12 0.11 0.12 0.18 0.176
Debt/EBITDA 2.89 3.02 3.12 3.12 3.66 2.68 2.59 3.42 2.32 2.13 1.87 1.45 1.38 1.26 1.24 1.20 1.17 1.09 1.14 1.64 1.642
Net Debt/EBITDA 1.45 1.39 1.73 1.72 1.87 1.38 1.48 2.49 1.63 1.22 1.12 0.89 0.73 0.59 0.63 0.54 0.50 0.26 0.70 0.96 0.956
Interest Coverage 7.46 7.72 8.28 9.36 8.54 9.80 11.17 10.70 13.79 13.96 14.06 16.81 19.82 25.70 30.16 33.22 38.12 41.72 49.32 56.35 56.348
Equity Multiplier 2.64 2.57 2.57 2.56 2.52 2.28 2.22 1.63 1.60 1.58 1.56 1.52 1.51 1.55 1.53 1.55 1.54 1.54 1.55 1.66 1.664
Cash Ratio snapshot only 0.468
Debt Service Coverage snapshot only 80.870
Cash to Debt snapshot only 0.418
FCF to Debt snapshot only 0.314
Defensive Interval snapshot only 508.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.63 0.61 0.62 0.62 0.66 0.68 0.71 0.50 0.56 0.61 0.67 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.54 0.53 0.529
Inventory Turnover 5.13 5.12 4.66 4.38 4.40 4.59 4.26 3.77 4.40 5.12 5.30 4.82 4.89 5.31 5.21 5.10 5.17 5.62 5.54 5.31 5.314
Receivables Turnover 5.40 5.54 5.31 5.23 5.36 5.39 5.34 4.51 5.06 5.43 5.75 5.04 5.01 5.21 5.08 4.97 5.07 5.27 5.14 4.92 4.917
Payables Turnover 6.04 5.33 5.51 5.25 5.58 5.05 5.19 4.66 5.40 5.50 6.06 5.56 5.67 5.42 5.63 5.46 5.79 5.51 5.79 5.38 5.383
DSO 68 66 69 70 68 68 68 81 72 67 63 72 73 70 72 73 72 69 71 74 74.2 days
DIO 71 71 78 83 83 80 86 97 83 71 69 76 75 69 70 72 71 65 66 69 68.7 days
DPO 60 68 66 70 65 72 70 78 68 66 60 66 64 67 65 67 63 66 63 68 67.8 days
Cash Conversion Cycle 78 69 81 84 86 75 84 99 88 72 72 83 83 71 77 78 80 68 74 75 75.1 days
Fixed Asset Turnover snapshot only 7.820
Operating Cycle snapshot only 142.9 days
Cash Velocity snapshot only 7.152
Capital Intensity snapshot only 1.900
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 7.6% 6.5% 4.0% 0.5% 1.8% 6.3% 9.3% 15.9% 26.5% 33.4% 39.5% 38.7% 24.8% 16.2% 8.1% 4.0% 5.6% 5.5% 5.7% 4.5% 4.55%
Net Income 1.1% 68.1% 39.3% 9.4% -31.0% -16.9% -11.8% -16.4% 54.2% 71.5% 78.2% 1.2% 68.7% 46.1% 36.7% 22.6% 14.2% 7.5% 7.4% 7.7% 7.68%
EPS 1.1% 68.0% 39.7% 9.8% -30.7% -16.7% -12.0% -27.0% 15.2% 28.8% 33.0% 84.5% 67.6% 44.8% 36.2% 22.5% 14.1% 7.4% 7.6% 11.0% 10.99%
FCF -21.5% -48.5% -57.9% -79.4% -56.2% 17.6% 69.8% 1.5% 1.3% 45.9% 44.2% 1.5% 63.3% 66.4% 37.0% -1.0% 11.7% -3.4% 8.7% 9.0% 8.97%
EBITDA 38.9% 35.7% 16.9% -0.4% -24.3% -12.7% -6.5% -3.7% 54.2% 54.3% 68.8% 90.8% 49.7% 51.2% 35.5% 21.7% 17.3% 5.4% 4.8% 5.1% 5.14%
Op. Income 62.9% 59.4% 28.2% 0.7% -9.5% 6.3% 14.0% 12.0% 12.9% 4.8% 13.7% 40.5% 49.4% 54.8% 41.2% 25.3% 19.3% 21.2% 19.9% 22.0% 21.98%
OCF Growth snapshot only 6.29%
Asset Growth snapshot only 0.88%
Equity Growth snapshot only -5.90%
Debt Growth snapshot only 43.83%
Shares Change snapshot only -2.99%
Dividend Growth snapshot only 11.69%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.0% -0.1% -0.1% -0.2% 0.5% 1.7% 3.5% 7.0% 11.5% 14.7% 16.6% 17.3% 17.1% 18.1% 18.2% 18.7% 18.5% 17.8% 16.9% 14.6% 14.65%
Revenue 5Y 7.4% 6.6% 5.5% 4.3% 3.4% 3.2% 3.3% 3.9% 5.8% 7.2% 8.7% 9.8% 9.9% 10.3% 10.9% 12.0% 12.8% 13.1% 12.7% 11.9% 11.91%
EPS 3Y 5.3% -8.1% -8.4% -9.7% -14.3% -4.0% 1.1% 6.9% 18.0% 21.7% 17.8% 13.9% 10.2% 15.8% 16.8% 18.2% 30.1% 26.1% 24.9% 35.9% 35.86%
EPS 5Y 7.2% 10.3% 11.0% 8.7% 0.6% 1.4% 1.0% -3.6% -1.4% -3.6% -2.1% -0.1% 4.0% 10.5% 13.4% 22.5% 25.7% 22.9% 19.1% 15.0% 14.99%
Net Income 3Y 5.4% -8.0% -8.4% -9.8% -14.4% -4.0% 1.1% 11.8% 30.0% 33.8% 29.8% 25.7% 21.6% 27.7% 29.0% 30.6% 43.8% 39.2% 37.8% 42.1% 42.10%
Net Income 5Y 7.4% 10.4% 11.0% 8.7% 0.6% 1.4% 1.0% -1.0% 4.5% 2.1% 3.8% 6.0% 10.3% 17.3% 20.3% 30.1% 33.4% 30.4% 26.3% 21.3% 21.28%
EBITDA 3Y -0.5% -3.6% -4.4% -5.0% -3.9% -0.6% 3.1% 10.5% 17.5% 22.3% 22.6% 22.3% 20.4% 26.7% 28.8% 30.8% 39.4% 34.9% 33.8% 34.6% 34.64%
EBITDA 5Y 8.9% 8.2% 6.1% 3.8% -1.7% -1.5% -1.6% -2.2% 2.8% 3.8% 6.6% 9.5% 15.4% 18.0% 20.2% 25.7% 23.3% 23.8% 21.2% 18.6% 18.56%
Gross Profit 3Y 0.3% -0.8% -1.5% -1.6% -0.8% 0.6% 3.0% 6.7% 11.2% 14.1% 15.2% 15.7% 15.7% 17.6% 18.3% 19.1% 19.3% 18.6% 17.5% 16.0% 16.00%
Gross Profit 5Y 6.8% 6.2% 4.8% 3.6% 2.8% 2.4% 2.6% 3.2% 4.9% 6.0% 7.5% 8.6% 8.7% 9.4% 10.3% 11.8% 13.1% 13.7% 12.9% 12.4% 12.39%
Op. Income 3Y -0.8% -3.6% -4.7% -5.5% 5.2% 8.6% 13.6% 24.2% 18.5% 21.1% 18.5% 16.6% 15.2% 19.9% 22.3% 25.4% 26.3% 25.3% 24.4% 29.0% 29.03%
Op. Income 5Y 7.3% 7.6% 6.4% 4.5% 3.1% 2.3% 2.0% 0.0% -0.0% -0.1% 2.3% 5.9% 14.5% 15.7% 18.7% 27.5% 24.3% 27.2% 23.0% 19.4% 19.37%
FCF 3Y 2.8% -1.8% -9.8% -25.1% -18.0% -14.1% -6.2% -16.8% -8.2% -4.1% 1.0% 9.2% 17.2% 41.9% 49.7% 84.2% 60.2% 32.9% 29.0% 39.1% 39.06%
FCF 5Y 8.1% -2.4% -6.9% -18.2% -12.9% -5.5% -2.4% -7.7% 1.4% 10.2% 12.4% 21.5% 15.2% 9.0% 10.2% 7.3% 7.1% 7.3% 9.0% 7.0% 7.05%
OCF 3Y -0.3% -2.8% -7.3% -14.9% -11.2% -10.8% -4.4% -11.0% -4.0% 0.5% 5.7% 12.3% 18.4% 32.9% 35.7% 49.8% 41.0% 27.7% 26.0% 31.4% 31.43%
OCF 5Y 7.6% 1.6% -1.0% -7.0% -5.5% -2.8% -1.1% -4.9% 1.4% 7.4% 9.3% 15.3% 12.0% 8.5% 9.9% 8.6% 8.6% 8.5% 10.5% 8.9% 8.86%
Assets 3Y 3.6% 4.6% 3.2% 2.2% 2.6% 1.0% 1.5% 24.0% 23.5% 22.6% 23.1% 21.5% 25.3% 25.8% 26.3% 28.0% 28.7% 30.4% 28.8% 2.5% 2.51%
Assets 5Y 11.3% 5.0% 4.7% 4.1% 3.6% 3.0% 1.6% 17.4% 16.8% 17.4% 16.4% 15.5% 16.4% 16.4% 16.9% 15.3% 15.4% 15.0% 14.7% 14.6% 14.57%
Equity 3Y 5.7% 5.1% 4.6% 3.4% 3.7% 5.7% 8.4% 51.3% 51.3% 50.7% 51.4% 50.4% 50.7% 49.0% 50.1% 51.3% 51.6% 48.7% 45.3% 1.7% 1.73%
Book Value 3Y 5.6% 5.1% 4.6% 3.5% 3.7% 5.7% 8.4% 44.7% 37.3% 37.1% 37.4% 36.3% 36.6% 35.1% 35.9% 36.9% 37.2% 34.7% 31.7% -2.7% -2.74%
Dividend 3Y 2.2% 2.5% 2.7% 2.8% 2.7% 2.2% 2.4% 0.6% -1.6% 1.2% 3.2% 0.5% -2.2% -4.5% -6.5% -6.4% -6.4% -6.0% -6.2% -1.8% -1.80%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.63 0.56 0.61 0.65 0.65 0.64 0.73 0.60 0.52 0.50 0.52 0.56 0.67 0.73 0.77 0.83 0.90 0.93 0.91 0.90 0.901
Earnings Stability 0.08 0.05 0.07 0.04 0.00 0.04 0.05 0.04 0.01 0.02 0.08 0.14 0.34 0.65 0.74 0.80 0.84 0.91 0.91 0.85 0.846
Margin Stability 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.99 0.99 0.98 0.98 0.977
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.84 0.96 0.88 0.93 0.95 0.93 0.50 0.50 0.50 0.50 0.50 0.82 0.85 0.91 0.94 0.97 0.97 0.97 0.969
Earnings Smoothness 0.31 0.49 0.67 0.91 0.63 0.82 0.87 0.82 0.57 0.47 0.44 0.26 0.49 0.63 0.69 0.80 0.87 0.93 0.93 0.93 0.926
ROE Trend 0.02 0.02 0.02 0.02 -0.01 -0.01 -0.01 -0.09 -0.07 -0.06 -0.05 -0.01 0.00 0.00 -0.00 0.03 0.02 0.01 0.01 0.02 0.018
Gross Margin Trend -0.00 -0.00 -0.01 -0.01 -0.00 -0.00 0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.019
FCF Margin Trend -0.01 -0.06 -0.07 -0.10 -0.07 -0.03 -0.01 -0.02 0.01 0.01 0.02 0.06 0.04 0.04 0.02 0.02 0.02 0.01 0.01 0.00 0.002
Sustainable Growth Rate 8.9% 7.2% 7.0% 6.7% 3.3% 4.1% 4.4% 1.6% 3.3% 4.5% 4.9% 4.2% 4.7% 5.2% 5.2% 5.3% 5.2% 5.1% 5.3% 5.7% 5.66%
Internal Growth Rate 3.3% 2.7% 2.6% 2.5% 1.3% 1.7% 1.9% 0.9% 1.9% 2.6% 2.9% 2.8% 3.1% 3.4% 3.5% 3.6% 3.5% 3.4% 3.5% 3.6% 3.65%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.49 1.26 1.14 0.86 1.42 1.68 1.77 1.63 1.51 1.37 1.43 1.58 1.38 1.42 1.33 1.30 1.34 1.30 1.35 1.29 1.288
FCF/OCF 0.75 0.61 0.55 0.39 0.50 0.65 0.68 0.62 0.68 0.68 0.69 0.74 0.72 0.75 0.74 0.72 0.73 0.73 0.73 0.74 0.738
FCF/Net Income snapshot only 0.950
OCF/EBITDA snapshot only 0.699
CapEx/Revenue 3.3% 4.0% 4.2% 4.3% 4.3% 3.8% 3.7% 3.6% 3.5% 3.7% 3.7% 3.8% 3.7% 3.7% 3.7% 3.9% 3.9% 3.7% 3.8% 3.7% 3.74%
CapEx/Depreciation snapshot only 0.605
Accruals Ratio -0.03 -0.01 -0.01 0.01 -0.02 -0.03 -0.04 -0.02 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.017
Sloan Accruals snapshot only -0.056
Cash Flow Adequacy snapshot only 1.751
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.9% 1.0% 1.4% 1.6% 1.4% 1.1% 1.2% 1.1% 1.3% 1.1% 1.1% 1.0% 1.1% 1.3% 1.2% 1.2% 1.1% 1.2% 1.4% 1.4% 1.72%
Dividend/Share $1.09 $1.12 $1.14 $1.17 $1.18 $1.20 $1.22 $1.19 $1.13 $1.24 $1.35 $1.38 $1.41 $1.44 $1.48 $1.52 $1.56 $1.60 $1.64 $1.70 $1.69
Payout Ratio 42.9% 47.5% 49.1% 50.1% 67.1% 61.1% 59.7% 69.9% 55.5% 49.1% 49.3% 43.8% 41.3% 39.3% 39.7% 39.6% 40.1% 40.9% 41.0% 39.8% 39.80%
FCF Payout Ratio 38.5% 61.5% 78.1% 1.5% 95.1% 55.9% 49.3% 68.9% 53.8% 52.8% 50.4% 37.6% 41.4% 37.2% 40.5% 42.1% 41.1% 43.0% 41.3% 41.9% 41.88%
Total Payout Ratio 57.6% 63.5% 61.4% 62.5% 83.4% 75.8% 62.1% 72.4% 57.5% 53.2% 54.1% 48.2% 45.4% 41.6% 41.7% 41.2% 41.7% 42.4% 99.1% 1.6% 1.63%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.08 0.09 0.10 0.10 0.09 0.08 0.08 0.18 0.29 0.39 0.48 0.37 0.27 0.18 0.11 0.12 0.12 0.13 0.12 0.10 0.098
Buyback Yield 0.3% 0.3% 0.4% 0.4% 0.3% 0.3% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 1.9% 4.5% 4.45%
Net Buyback Yield 0.2% 0.3% 0.3% 0.3% 0.3% 0.2% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% -0.0% 1.9% 4.4% 4.38%
Total Shareholder Return 1.2% 1.3% 1.7% 1.9% 1.7% 1.4% 1.2% 1.1% 1.3% 1.2% 1.2% 1.1% 1.2% 1.3% 1.3% 1.2% 1.1% 1.2% 3.2% 5.8% 5.82%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.85 0.84 0.85 0.85 0.85 0.81 0.79 0.79 0.80 0.96 0.94 0.91 0.90 0.82 0.82 0.81 0.80 0.81 0.81 0.79 0.793
Interest Burden (EBT/EBIT) 0.87 0.87 0.88 0.89 0.88 0.90 0.91 0.91 0.93 0.93 0.93 0.94 0.95 0.96 0.97 0.97 0.97 0.98 0.98 0.98 0.982
EBIT Margin 0.12 0.11 0.11 0.11 0.08 0.09 0.09 0.08 0.10 0.09 0.10 0.11 0.12 0.13 0.13 0.14 0.14 0.13 0.14 0.14 0.142
Asset Turnover 0.63 0.61 0.62 0.62 0.66 0.68 0.71 0.50 0.56 0.61 0.67 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.54 0.53 0.529
Equity Multiplier 2.79 2.75 2.73 2.72 2.58 2.42 2.38 1.85 1.83 1.76 1.73 1.57 1.56 1.57 1.55 1.54 1.53 1.54 1.54 1.61 1.607
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.54 $2.35 $2.33 $2.33 $1.76 $1.96 $2.05 $1.70 $2.03 $2.52 $2.73 $3.14 $3.41 $3.65 $3.72 $3.85 $3.88 $3.92 $4.00 $4.27 $4.27
Book Value/Share $17.03 $17.72 $17.67 $17.69 $17.77 $19.27 $19.73 $47.88 $41.00 $42.09 $41.95 $42.46 $43.46 $43.65 $44.36 $45.41 $45.91 $47.05 $45.09 $44.05 $44.49
Tangible Book/Share $-4.19 $-3.25 $-3.24 $-2.74 $-1.96 $-0.85 $-0.41 $-1.92 $-1.07 $0.21 $0.95 $1.88 $2.77 $1.16 $1.74 $1.98 $2.49 $3.59 $1.92 $0.06 $0.06
Revenue/Share $28.88 $28.61 $28.79 $28.93 $29.51 $30.46 $31.43 $29.29 $27.88 $30.50 $32.71 $34.48 $34.56 $35.11 $35.26 $35.80 $36.44 $37.03 $37.36 $38.58 $38.62
FCF/Share $2.83 $1.82 $1.46 $0.78 $1.24 $2.14 $2.48 $1.73 $2.09 $2.34 $2.67 $3.65 $3.40 $3.86 $3.65 $3.61 $3.79 $3.73 $3.97 $4.06 $4.06
OCF/Share $3.79 $2.96 $2.67 $2.02 $2.51 $3.29 $3.63 $2.77 $3.07 $3.47 $3.89 $4.95 $4.69 $5.18 $4.95 $5.02 $5.22 $5.09 $5.41 $5.50 $5.51
Cash/Share $6.91 $7.43 $6.17 $6.16 $6.56 $5.21 $4.62 $3.42 $2.91 $4.22 $3.90 $3.35 $4.06 $4.60 $4.34 $4.80 $4.88 $6.06 $3.32 $5.39 $3.00
EBITDA/Share $4.82 $4.58 $4.44 $4.38 $3.66 $4.00 $4.15 $3.69 $4.22 $4.64 $5.22 $5.97 $6.27 $6.94 $7.05 $7.25 $7.35 $7.31 $7.40 $7.86 $7.86
Debt/Share $13.90 $13.82 $13.85 $13.68 $13.41 $10.75 $10.74 $12.60 $9.79 $9.90 $9.77 $8.64 $8.63 $8.72 $8.76 $8.71 $8.56 $7.96 $8.47 $12.91 $12.91
Net Debt/Share $6.99 $6.39 $7.67 $7.52 $6.85 $5.54 $6.13 $9.17 $6.88 $5.68 $5.87 $5.29 $4.57 $4.12 $4.42 $3.91 $3.68 $1.90 $5.15 $7.52 $7.52
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.633
Altman Z-Prime snapshot only 6.122
Piotroski F-Score 6 7 7 6 7 7 7 5 6 5 5 7 8 7 8 7 8 7 8 7 7
Beneish M-Score -2.60 -2.51 -2.43 -2.41 -2.62 -2.50 -2.58 -1.79 -1.69 -1.84 -1.88 -2.55 -2.54 -2.59 -2.49 -2.46 -2.51 -2.49 -2.54 -2.56 -2.564
Ohlson O-Score snapshot only -9.102
ROIC (Greenblatt) snapshot only 45.68%
Net-Net WC snapshot only $-10.67
EVA snapshot only $-172954438.33
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 79.23 72.87 67.34 66.69 66.95 77.37 81.96 67.16 75.22 78.64 83.60 86.76 87.38 89.47 89.31 89.04 91.14 90.00 89.62 84.55 84.546
Credit Grade snapshot only 4
Credit Trend snapshot only -4.489
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 72
Sector Credit Rank snapshot only 78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms